Breaking Down the Numbers: AbbVie’s Impressive Third Quarter 2024 Financial Report
Welcome to AbbVie’s Third Quarter Financial Report Highlights of the Third Quarter Financial Results AbbVie reported a third-quarter diluted EPS of $0.88 on a GAAP basis, a decrease of 12.0 percent. However, the adjusted diluted EPS was $3.00, an increase of 1.7 percent. These results include an unfavorable impact of $0.04 per share related to…